FALCON POINT CAPITAL, LLC - AEGERION PHARMACEUTICALS INC ownership

AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 18 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
FALCON POINT CAPITAL, LLC ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$1,217,000
+1.4%
1,500,0000.0%0.16%
+2.5%
Q1 2017$1,200,000
+12.3%
1,500,0000.0%0.16%
+11.9%
Q4 2016$1,069,000
+14.1%
1,500,0000.0%0.14%0.0%
Q3 2016$937,000
+9.6%
1,500,0000.0%0.14%
-3.4%
Q2 2016$855,000
+12.2%
1,500,0000.0%0.15%
+12.1%
Q1 2016$762,000
-23.5%
1,500,0000.0%0.13%
-38.6%
Q4 2015$996,000
-11.2%
1,500,0000.0%0.22%
-46.4%
Q3 2015$1,121,0001,500,0000.40%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Context Capital Management, LLC 1,760,000$898,0001.12%
Telemetry Investments, L.L.C. 6,000,000$3,049,0000.89%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 54,500,000$27,693,0000.46%
ZAZOVE ASSOCIATES LLC 15,070,000$7,761,0000.37%
ACUTA CAPITAL PARTNERS, LLC 1,000,000$508,0000.28%
Tekla Capital Management LLC 13,000,000$6,606,0000.28%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 26,000,000$13,910,000,0000.26%
Castle Creek Arbitrage, LLC 4,000,000$2,081,0000.17%
WOLVERINE ASSET MANAGEMENT LLC 10,934,000$5,558,0000.16%
Baker Brothers Advisors 26,517,000$13,526,0000.14%
View complete list of AEGERION PHARMACEUTICALS INC shareholders